379
60. Pereira-Fernandes A, Demaegdt H, Vandermeiren K, Hectors TL, Jorens PG, Blust R, et al.
Evaluation of a screening system for obesogenic compounds: screening of endocrine disrupting compounds and evaluation of the PPAR dependency of the effect. PLoS One. 2013;8:10.
61. Kodani SD, Overby HB, Morisseau C, Chen J, Zhao L, Hammock BD. Parabens inhibit fatty
acid amide hydrolase: A potential role in paraben-enhanced 3T3-L1 adipocyte differentiation.
Toxicol Lett. 2016;262:92–9.
62. Kolatorova L, Sramkova M, Vitku J, Vcelak J, Lischkova O, Starka L, et al. Parabens and their
relation to obesity. Physiol Res. 2018;67:S465–S72.
63. Chen C, Gong X, Yang X, Shang X, Du Q, Liao Q, et al. The roles of estrogen and estrogen
receptors in gastrointestinal disease. Oncol Lett. 2019;18(6):5673–80.
64. Findlay J, Liew SH, Simpson ER, Korach KS. Estrogen signaling in the regulation of female
reproductive functions. In: Fertility control. London: Springer; 2010. p. 29–35.
65. Miller WL. Steroidogenic enzymes. In: Disorders of the human adrenal cortex, vol. 13. Basel:
Karger; 2008. p. 1–18.
66. Gunnarsson C, Hellqvist E, Stål O. 17 β-Hydroxysteroid dehydrogenases involved in local oestrogen synthesis have prognostic significance in breast cancer. Br J Cancer. 2005;92(3):547–52.
67. Engeli RT, Rohrer SR, Vuorinen A, Herdlinger S, Kaserer T, Leugger S, et al. Interference of
paraben compounds with estrogen metabolism by inhibition of 17β-hydroxysteroid dehydrogenases. Int J Mol Sci. 2017;18(9):2007.
68. Byford J, Shaw L, Drew M, Pope G, Sauer M, Darbre P. Oestrogenic activity of parabens in
MCF7 human breast cancer cells. J Steroid Biochem Mol Biol. 2002;80(1):49–60.
22 Parabens as Endocrine Disrupting Chemicals and Their Association…
Précédent

- 389/526

Suivant